- We expect sales growth of 13.3% to INR15.4b led by 8% domestic organic volume growth.
- Benefits from recent distribution expansion should support volume growth, in our view.
- Dabur has stepped up activity in the oral care space and launched Babool Salt.
- We expect low teens growth in international division.
- Expect margin expansion of 90bp to 16.7% due to correction in input costs; in line with management guidance.
- We estimate 14% PAT growth to INR1.94b.
- The stock trades at 24.9x FY14E EPS and 20.6x FY15E EPS. Buy.
